Paper99034
Platinum nephrotoxicity.
Madias NE and 1 other. Am J Med, 1978. Cited by 497 papers, by iCite.
Cite this record
ConductScience Library. Platinum nephrotoxicity. Papers, record 99034. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/99034
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acute Kidney Injury | Major topic |
| Cisplatin | Major topic |
| Kidney | Major topic |
| Kidney Tubular Necrosis, Acute | Major topic |
| Animals | |
| Callitrichinae | |
| Clinical Trials as Topic | |
| Dogs | |
| Drug Evaluation, Preclinical | |
| Haplorhini | |
| Humans | |
| Injections, Intravenous | |
| Kidney Function Tests | |
| Kidney Tubules | |
| Kidney Tubules, Proximal | |
| Macaca mulatta | |
| Male | |
| Mice | |
| Neoplasms | |
| Neoplasms, Experimental | |
| Rabbits | |
| Rats |
Source PubMed
Cited by119
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 497 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42831533 | Quercetin Attenuates Cisplatin-Induced Nephrotoxicity While Enhancing Antitumor Efficacy in Gastric Cancer via Cell Type-Specific Modulation of the ERK1/2 Pathway. | J Biochem Mol Toxicol | 2026 | https://conductscience.org/library/papers/42831533 | PubMed |
| 41778253 | Prolonged Renal Dysfunction in Patients Undergoing Chemotherapy for Locally Advanced Esophageal Cancer: Treatment Implications and Risk Factors. | Cancer Diagn Progn | 2026 | https://conductscience.org/library/papers/41778253 | PubMed |
| 41592613 | Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial. | JMIR Res Protoc | 2026 | https://conductscience.org/library/papers/41592613 | PubMed |
| 41288783 | Hydration practices during cisplatin administration: a national multicenter survey. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/41288783 | PubMed |
| 40526606 | EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients. | PLoS One | 2025 | https://conductscience.org/library/papers/40526606 | PubMed |
| 39681358 | Remote organ cancer induces kidney injury, inflammation, and fibrosis and adversely alters renal function. | Am J Physiol Renal Physiol | 2025 | https://conductscience.org/library/papers/39681358 | PubMed |
| 39605909 | Predicting adverse drug event using machine learning based on electronic health records: a systematic review and meta-analysis. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39605909 | PubMed |
| 39494507 | Intraoperative hyperthermia is associated with increased acute kidney injury following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective cohort study. | Ren Fail | 2024 | https://conductscience.org/library/papers/39494507 | PubMed |
| 39192240 | Time-course analysis of cisplatin induced AKI in preclinical models: implications for testing different sources of MSCs. | J Transl Med | 2024 | https://conductscience.org/library/papers/39192240 | PubMed |
| 39022464 | The Use of Amiloride and Sodium-Glucose Cotransporter 2 Inhibitors in Cisplatin-Induced Hypomagnesemia: A Case Report and Review of the Literature. | Cureus | 2024 | https://conductscience.org/library/papers/39022464 | PubMed |
| 38714773 | Comparison of preventive effects of combined furosemide and mannitol versus single diuretics, furosemide or mannitol, on cisplatin-induced nephrotoxicity. | Sci Rep | 2024 | https://conductscience.org/library/papers/38714773 | PubMed |
| 38418143 | Evaluation of Prediabetes in Cisplatin-induced Nephrotoxicity in the Short Hydration Method: A Subgroup Analysis. | In Vivo | 2024 | https://conductscience.org/library/papers/38418143 | PubMed |
| 38410567 | Cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy for the treatment of thymic epithelial malignancies with pleural spread or recurrence (CHOICE): a study protocol for a prospective, open, single-arm study. | J Thorac Dis | 2024 | https://conductscience.org/library/papers/38410567 | PubMed |
| 38148888 | The Effect of Donor Rat Gender in Mitochondrial Transplantation Therapy of Cisplatin-Induced Toxicity on Rat Renal Proximal Tubular Cells. | Iran J Pharm Res | 2023 | https://conductscience.org/library/papers/38148888 | PubMed |
| 37816823 | Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients. | Sci Rep | 2023 | https://conductscience.org/library/papers/37816823 | PubMed |
| 36528725 | Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis. | Sci Rep | 2022 | https://conductscience.org/library/papers/36528725 | PubMed |
| 36401337 | Capsaicin alleviates cisplatin-induced muscle loss and atrophy in vitro and in vivo. | J Cachexia Sarcopenia Muscle | 2023 | https://conductscience.org/library/papers/36401337 | PubMed |
| 35832084 | MiR-155 deficiency protects renal tubular epithelial cells from telomeric and genomic DNA damage in cisplatin-induced acute kidney injury. | Theranostics | 2022 | https://conductscience.org/library/papers/35832084 | PubMed |
| 35632435 | Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35632435 | PubMed |
| 35436142 | The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial. | JCO Glob Oncol | 2022 | https://conductscience.org/library/papers/35436142 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/99034
GET https://conductscience.org/api/papers/v1/99034/cited_by?page=2